Success Story: NIW Approved After RFE, NAILG Builds a Cohesive Record for Molecular Microbiology Research in Fungal Pathogenesis
Client’s Testimonial:
"I had excellent experience working with NAILA on my EB-2 NIW petition. From the initial assessment through final approval, their team was thorough, responsive, and strategically sharp. They helped me frame my work clearly within the NIW criteria and provided detailed guidance on structuring evidence to strengthen the petition.
When I received an RFE, they approached it calmly and methodically, helping me craft a precise, well-supported response that directly addressed each concern. Their support with drafting and refining reference letters was especially valuable—they ensured the letters were substantive, tailored, and aligned with the overall legal strategy rather than generic endorsements.
Throughout the process, communication was clear and timelines were well managed. I felt confident at every stage knowing my case was being handled with care and expertise. I would strongly recommend NAILA to anyone pursuing an EB-2 NIW petition."
On January 15th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Molecular Microbiology (Approval Notice).
General Field: Molecular Microbiology
Position at the Time of Case Filing: Postdoctoral Researcher
Approval Notice Date: January 15th, 2026
Processing Time: 6 months, 8 days (Premium Processing Requested)
Case Summary:
Hospital fungal infections are rarely “sudden.” In many cases, the risk builds quietly when fungal pathogens establish a foothold in the gastrointestinal tract and later disseminate under the wrong conditions, especially in medically vulnerable patients. This NIW case highlighted a molecular microbiology researcher working to define the host and microbial factors that regulate gastrointestinal fungal colonization and to translate those findings into approaches that limit pathogen expansion.
North America Immigration Law Group (Chen Immigration Law Associates) used the RFE phase to sharpen how the evidence connected the client’s research direction to public-health consequences in the United States and to demonstrate that the client’s work was already being relied upon in the field.
Because the case received an RFE, the response needed to show more than promise. It needed to show that the client’s research was already shaping what others do in the field. The record established that trajectory through key sources of objective proof:
- Technical foundation tied to the endeavor: The client holds a Ph.D. in Molecular Microbiology, supporting deep training in the tools and frameworks required to study host-pathogen interactions and microbial mechanisms in the gut.
- A compact but high-impact publication record: The client authored 5 peer-reviewed journal articles. The case did not treat “five papers” as automatically sufficient. Instead, it emphasized how the publication venues and the subsequent use of the work demonstrated field-level interest in the findings.
- Independent reliance, not just visibility: The client’s work had 203 citations at the time of filing, and the RFE response further emphasized independent uptake and concrete examples of how other researchers relied on specific findings and models. This distinction mattered because citations are most persuasive in NIW cases when they show utilization: other teams using the work as an input to their own investigations.
- Research Support: The record also highlighted that the client’s research has been supported by the National Institutes of Health (NIH), underscoring the national importance of the work.
USCIS approved the NIW petition on January 15th, 2026, after the RFE was issued on September 5th, 2025. The approval reflects a record that tied a clearly defined endeavor to a realistic mechanism of impact and supported it with objective proof of readiness, including a Ph.D. foundation, a first-authored publication record, independent citations, and NIH-backed research support. NAILG was honored to present the client’s case in a way that made the science understandable and the national-interest value easy to credit.